Abstract 4363598: Is Age Just a Number? A Nationwide Multicenter Analysis of Post-Ablation Safety in Elderly Atrial Fibrillation Patients

Y Yu-Chiang Wang (University of Hawaii, Honolulu, Hawaii, United States) R Rebecca Hsieh (Danbury Hospital, Danbury, Connecticut, United States) P Pei-Lun Lee (Jacobi Medical Center, Bronx, New York, United States) K Kuan Yu Chi (Jacobi Medical Center, Bronx, New York, United States) A Agara Kumar (Danbury Hospital, Danbury, Connecticut, United States) R Rahul Ahuja (John A Burn School of Medicine, University of Hawaii, Honolulu, Hawaii, United States) P Pattara Rattanawong (Massachusetts General Hospital, Boston, Massachusetts, United States)

Abstract

Background: Evidence regarding the safety profile of atrial fibrillation (AF) catheter ablation remains limited. As life expectancy increases, a rising number of elderly patients are considered candidates for this procedure. Research Question: What is the safety profile of AF ablation in elderly patients with new AF in a real-world setting? Methods: In this U.S.-based multicenter cohort study (TriNetX dataset), we identified adults (≥ 60 years old) with new AF who underwent catheter ablation within 6 months. Patients were grouped by age at first AF episode: 60–79 years (older adults) and ≥80 years (elderly adults). Patients with prior surgical ablation were excluded. Propensity score matching (1:1) balanced groups by demographics, comorbidities, and medications. The primary end point was repeat AF ablation at 1-year; secondary endpoints included new or ongoing antiarrhythmic (AAD) use, ischemic stroke, safety outcomes of heart failure (HF) exacerbations, pericardial complications (pericardial effusion, tamponade or hemopericardium), new venous thromboembolism (VTE), cardiac arrest, conduction disease (new complete heart block or sick sinus syndrome), vascular access complications (post-procedural hematomas or aneurysms), all-cause hospitalizations, and all-cause mortality. Falsification outcomes included urinary tract infections (UTI) and herpes zoster. Kaplan-Meier analysis and log-rank tests compared outcomes; hazard ratios (HRs) with 95% CI were calculated using Cox regression. Results: After matching (N= 5,032 per group), elderly adults were less likely to undergo repeat catheter ablation at 1-year. AAD use and VTE risks were similar between groups. Elderly adults had higher risk of ischemic stroke (HR=1.27, 95% CI = 0.91-1.01, p=0.12) and HF exacerbation (HR=1.67, 95% CI=1.39-2.0, p<0.01). Safety outcomes were similar, however elderly adults were at risk of new conduction disease (HR=1.91, 95% CI = 1.58-2.31, p<0.01). Elderly adults were more likely to be hospitalized (HR= 1.36, 95% CI = 1.26-1.46, p<0.01) and had higher risk of mortality (HR=1.78, 95% CI=1.45-2.22, p<0.01). Falsification outcomes found elderly adults had higher UTI risk (HR=1.68, 95% CI=1.43-1.97, p<0.01). Conclusion: Elderly adults (≥80 years) undergoing catheter ablation had significantly higher risk of complications compared to older adults (60-79 years), underscoring the need for further investigations to mitigate periprocedural risk in AF catheter ablation.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (7)

Y

Yu-Chiang Wang

University of Hawaii, Honolulu, Hawaii, United States

R

Rebecca Hsieh

Danbury Hospital, Danbury, Connecticut, United States

P

Pei-Lun Lee

Jacobi Medical Center, Bronx, New York, United States

K

Kuan Yu Chi

Jacobi Medical Center, Bronx, New York, United States

A

Agara Kumar

Danbury Hospital, Danbury, Connecticut, United States

R

Rahul Ahuja

John A Burn School of Medicine, University of Hawaii, Honolulu, Hawaii, United States

P

Pattara Rattanawong

Massachusetts General Hospital, Boston, Massachusetts, United States